Drug intelligence / Profile preview

meso-tetra-4-pyridyl porphine

Development stage
Preclinical
Lead developer
Wake Forest University
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal, Topical, Percutaneous
01

Overview

meso-tetra-4-pyridyl porphine (MTP) is a synthetic porphyrin derivative that serves as a photosensitizer in photodynamic therapy (PDT). It is characterized by its ability to non-covalently assemble with single-stranded DNA (ssDNA) to form stable, nano-sized complexes (PDN) under physiological conditions. These complexes are designed for pH-dependent release, dissociating in acidic environments such as the endosomal compartments of cancer cells (pH ~5.1) where the pyridyl nitrogens of MTP become protonated. Upon exposure to light, MTP generates reactive oxygen species (ROS), which induce localized membrane damage and lipid peroxidation, leading to cell death. Research conducted at Wake Forest University has demonstrated that MTP-DNA complexes exhibit significant anti-tumor activity in bladder cancer xenograft models, suggesting potential applications in targeted cancer treatment and drug delivery.

Other names
meso-tetra(4-pyridyl)porphyrinT4PyPT-4PyPT 4PyP5,10,15,20-tetra(4-pyridyl)-21H,23H-porphine
02

Targets

ssDNA (Single-stranded DNA)

Beyond the preview

Go deeper on meso-tetra-4-pyridyl porphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on meso-tetra-4-pyridyl porphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call